NM504 is designed to improve glucose tolerance and other metabolic parameters in patients with diabetes by shifting the gastrointestinal microbiome–the micro-organisms that inhabit the human body.
Read more
Diabetes Health – Successful Clinical Trial of Type 2 Drug That Works on Intestinal Organisms